The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...

Of these, more than 4.5 lakh treatments worth over Rs 985 crore were undertaken for "targeted therapies" against cancer, with ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Over 68 lakh cancer treatments under the Ayushman Bharat scheme, valued at over Rs 13,000 crore, have been performed, with 76 ...

Researchers at UC San Diego have developed advanced deep learning techniques that could revolutionize treatment planning for breast cancer radiotherapy – making it faster and improving its quality.

Dr. Moghanaki joins a prestigious board of lung cancer experts committed to attracting top researchers to the field of lung cancer research Dr. Drew Moghanaki Dr. Drew Moghanaki, Chief of Thoracic ...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...

Advances in medicine mean more kids than ever beat cancer, but that’s just the beginning. Many childhood cancer survivors face long-term health challenges caused by the very treatments that saved them ...

Health Minister J P Nadda on Tuesday said that more than 68 lakh cancer treatments worth over Rs 13,000 crore have been performed under the Ayushman Bharat health insurance scheme. Nadda maintained ...

Cancer survivors lash out at Kellie Finlayson fan who suggests she ditch conventional cancer treatment in Australia and try ...